Prognostic factors and survival in gastroenteropancreatic neuroendocrine neoplasm: Real-world evidence from a South American Single-Center Cohort
- 11 October 2025
- journal article
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 86 (5) , 102463
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Tumores neuroendocrinos gastroenteropancreáticos: un estudio retrospectivo en el suroccidente colombianoRevista de Gastroenterología de México, 2025
- Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based studyThe Lancet Regional Health - Europe, 2022
- The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasmsEuropean Journal of Cancer, 2022
- Overview of the 2022 WHO Classification of Neuroendocrine NeoplasmsEndocrine Pathology, 2022
- Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United StatesJAMA Network Open, 2021
- An updated analysis of the epidemiologic trends of neuroendocrine tumors in TaiwanScientific Reports, 2021
- Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?Current Oncology Reports, 2021
- Chilean Registry for Neuroendocrine Tumors: A Latin American PerspectiveDiscover Oncology, 2018
- Resultados del tratamiento multidisciplinario de tumores neuroendocrinos de intestino delgadoRevista Colombiana de Cancerología, 2018
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesJAMA Oncology, 2017